Inovio Pharmaceuticals Inc (INO) — Capital Reinvestment Ratio
Latest as of September 2015:
0.05x
Inovio Pharmaceuticals Inc (INO) has a Capital Reinvestment Ratio of 0.05x as of September 2015, meaning it reinvests 0% of its operating cash flow ($15.42 Million) in capital expenditures ($782.60K). Check INO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$15.42 Million
USD
Capital Expenditures
$782.60K
USD
Data as of
Sep 2015
Most recent filing
Annual Capital Reinvestment Ratio for Inovio Pharmaceuticals Inc (None–None)
Year-by-year Capital Reinvestment Ratio for Inovio Pharmaceuticals Inc from None to None. See cash generation quality of Inovio Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow